Martin F. Pera - Publications

Affiliations: 
Systems Biology and Disease University of Southern California, Los Angeles, CA, United States 
Area:
Human Development, Medicine and Surgery, Cell Biology

177 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Arthur TD, Nguyen JP, D'Antonio-Chronowska A, Matsui H, Silva NS, Joshua IN, Luchessi AD, Greenwald WWY, D'Antonio M, Pera MF, Frazer KA. Complex regulatory networks influence pluripotent cell state transitions in human iPSCs. Nature Communications. 15: 1664. PMID 38395976 DOI: 10.1038/s41467-024-45506-6  0.309
2023 Ludwig TE, Andrews PW, Barbaric I, Benvenisty N, Bhattacharyya A, Crook JM, Daheron LM, Draper JS, Healy LE, Huch M, Inamdar MS, Jensen KB, Kurtz A, Lancaster MA, Liberali P, ... ... Pera MF, et al. ISSCR standards for the use of human stem cells in basic research. Stem Cell Reports. 18: 1744-1752. PMID 37703820 DOI: 10.1016/j.stemcr.2023.08.003  0.507
2023 Pera MF. Seven days in the life cycle of Homo sapiens. Cell. 186: 3755-3757. PMID 37657417 DOI: 10.1016/j.cell.2023.08.007  0.412
2023 Rivron NC, Martinez Arias A, Pera MF, Moris N, M'hamdi HI. An ethical framework for human embryology with embryo models. Cell. 186: 3548-3557. PMID 37595564 DOI: 10.1016/j.cell.2023.07.028  0.344
2023 Arthur TD, Nguyen JP, D'Antonio-Chronowska A, Matsui H, Silva N, Joshua IN, Young Greenwald WW, D'Antonio M, Pera MF, Frazer KA. Unsupervised Machine Learning Identifies Chromatin Accessibility Regulatory Networks that Define Cell State Transitions in Pluripotency. Biorxiv : the Preprint Server For Biology. PMID 37292794 DOI: 10.1101/2023.05.20.541447  0.419
2023 Pera MF. A step closer to making the mother of stem cells. Nature. 617: 683-684. PMID 37198461 DOI: 10.1038/d41586-022-01932-4  0.516
2022 Andrews PW, Barbaric I, Benvenisty N, Draper JS, Ludwig T, Merkle FT, Sato Y, Spits C, Stacey GN, Wang H, Pera MF. The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells. Cell Stem Cell. 29: 1624-1636. PMID 36459966 DOI: 10.1016/j.stem.2022.11.006  0.49
2022 De Los Angeles A, Regenberg A, Mascetti V, Benvenisty N, Church G, Deng H, Izpisua Belmonte JC, Ji W, Koplin J, Loh YH, Niu Y, Pei D, Pera M, Pho N, Pinzon-Arteaga C, et al. Why it is important to study human-monkey embryonic chimeras in a dish. Nature Methods. PMID 35879609 DOI: 10.1038/s41592-022-01571-7  0.528
2022 Pera MF. Pluripotent cell states and unexpected fates. Stem Cell Reports. 17: 1235-1236. PMID 35705011 DOI: 10.1016/j.stemcr.2022.05.011  0.611
2022 Chakraborty AR, Vassilev A, Jaiswal SK, O'Connell CE, Ahrens JF, Mallon BS, Pera MF, DePamphilis ML. Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors. Stem Cell Reports. PMID 35063131 DOI: 10.1016/j.stemcr.2021.12.013  0.548
2021 Pera MF, Rossant J. The exploration of pluripotency space: Charting cell state transitions in peri-implantation development. Cell Stem Cell. 28: 1896-1906. PMID 34672948 DOI: 10.1016/j.stem.2021.10.001  0.368
2021 Pera M. Updates for contributors: Rigor and reproducibility in stem cell research. Stem Cell Reports. 16: 1645. PMID 33989518 DOI: 10.1016/j.stemcr.2021.05.001  0.516
2021 Hayes K, Kim YK, Pera MF. The case for revisiting Nodal signaling in human pluripotent stem cells. Stem Cells (Dayton, Ohio). PMID 33932319 DOI: 10.1002/stem.3383  0.497
2020 Pera M. Diversity, Equity, and Inclusion in Stem Cell Research. Stem Cell Reports. PMID 32916122 DOI: 10.1016/J.Stemcr.2020.08.014  0.586
2020 Lau KX, Mason EA, Kie J, De Souza DP, Kloehn J, Tull D, McConville MJ, Keniry A, Beck T, Blewitt ME, Ritchie ME, Naik SH, Zalcenstein D, Korn O, Su S, ... ... Pera MF, et al. Unique properties of a subset of human pluripotent stem cells with high capacity for self-renewal. Nature Communications. 11: 2420. PMID 32415101 DOI: 10.1038/S41467-020-16214-8  0.668
2020 Pera M. Message from the Editor: Stem Cell Science in the Time of COVID-19. Stem Cell Reports. 14: 529. PMID 32243846 DOI: 10.1016/J.Stemcr.2020.03.022  0.577
2020 Eaves CJ, Pera MF. Cancer Stem Cells: Notes for Authors. Stem Cell Reports. 14: 167-168. PMID 32049060 DOI: 10.1016/J.Stemcr.2020.01.011  0.578
2020 Hyun I, Munsie M, Pera MF, Rivron NC, Rossant J. Toward Guidelines for Research on Human Embryo Models Formed from Stem Cells. Stem Cell Reports. PMID 31951813 DOI: 10.1016/J.Stemcr.2019.12.008  0.519
2019 Harkness L, Chen X, Jia Z, Davies AM, Monteiro M, Gray P, Pera M. Fibronectin-conjugated thermoresponsive nanobridges generate three dimensional human pluripotent stem cell cultures for differentiation towards the neural lineages. Stem Cell Research. 38: 101441. PMID 31082678 DOI: 10.1016/J.Scr.2019.101441  0.584
2019 Farley AM, Braxton DR, Li J, Trounson K, Sakar-Dey S, Nayer B, Ikeda T, Lau KX, Hardikar W, Hasegawa K, Pera MF. Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma. Scientific Reports. 9: 2876. PMID 30814526 DOI: 10.1038/S41598-019-38988-8  0.399
2019 Pera M. Biomedical engineering: In vitro amniogenesis. Nature Materials. 16: 394-395. PMID 28352098 DOI: 10.1038/Nmat4885  0.563
2018 Rivron N, Pera M, Rossant J, Martinez Arias A, Zernicka-Goetz M, Fu J, van den Brink S, Bredenoord A, Dondorp W, de Wert G, Hyun I, Munsie M, Isasi R. Debate ethics of embryo models from stem cells. Nature. 564: 183-185. PMID 30542177 DOI: 10.1038/D41586-018-07663-9  0.451
2018 Abbot S, Agbanyo F, Ahlfors JE, Baghbaderani BA, Bartido S, Bharti K, Burke C, Carlsson B, Cavagnaro J, Creasey A, DiGiusto D, Francissen K, Gaffney A, Goldring C, Gorba T, ... ... Pera M, et al. Report of the international conference on manufacturing and testing of pluripotent stem cells. Biologicals : Journal of the International Association of Biological Standardization. PMID 30150108 DOI: 10.1016/J.Biologicals.2018.08.004  0.506
2018 Baker CL, Pera MF. Capturing Totipotent Stem Cells. Cell Stem Cell. 22: 25-34. PMID 29304340 DOI: 10.1016/J.Stem.2017.12.011  0.589
2017 Hurlbut JB, Hyun I, Levine AD, Lovell-Badge R, Lunshof JE, Matthews KRW, Mills P, Murdoch A, Pera MF, Scott CT, Tizzard J, Warnock M, Zernicka-Goetz M, Zhou Q, Zoloth L. Revisiting the Warnock rule. Nature Biotechnology. 35: 1029-1042. PMID 29121021 DOI: 10.1038/Nbt.4015  0.313
2017 Kim JH, Kurtz A, Yuan BZ, Zeng F, Lomax G, Loring JF, Crook J, Ju JH, Clarke L, Inamdar MS, Pera M, Firpo MT, Sheldon M, Rahman N, O'Shea O, et al. Proceedings: Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells. Stem Cells Translational Medicine. PMID 29067781 DOI: 10.1002/Sctm.17-0144  0.638
2017 Bellmaine SF, Ovchinnikov DA, Manallack DT, Cuddy CE, Elefanty AG, Stanley EG, Wolvetang EJ, Williams SJ, Pera M. Inhibition of DYRK1A disrupts neural lineage specification in human pluripotent stem cells. Elife. 6. PMID 28884684 DOI: 10.7554/Elife.24502  0.621
2017 Gazina EV, Morrisroe E, Mendis GDC, Michalska AE, Chen J, Nefzger CM, Rollo BN, Reid CA, Pera MF, Petrou S. Method of derivation and differentiation of mouse embryonic stem cells generating synchronous neuronal networks. Journal of Neuroscience Methods. PMID 28827162 DOI: 10.1016/J.Jneumeth.2017.08.018  0.467
2017 Andrews PW, Ben-David U, Benvenisty N, Coffey P, Eggan K, Knowles BB, Nagy A, Pera M, Reubinoff B, Rugg-Gunn PJ, Stacey GN. Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications. Stem Cell Reports. 9: 1-4. PMID 28700896 DOI: 10.1016/J.Stemcr.2017.05.029  0.615
2017 Crombie DE, Curl CL, Raaijmakers AJ, Sivakumaran P, Kulkarni T, Wong RC, Minami I, Evans-Galea MV, Lim SY, Delbridge L, Corben LA, Dottori M, Nakatsuji N, Trounce IA, Hewitt AW, ... ... Pera MF, et al. Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency. Aging. PMID 28562313 DOI: 10.18632/Aging.101247  0.446
2017 Pera MF. Human embryo research and the 14-day rule. Development (Cambridge, England). 144: 1923-1925. PMID 28559237 DOI: 10.1242/Dev.151191  0.461
2017 Pera M. Embryogenesis in a dish Science. 356: 137-138. PMID 28408561 DOI: 10.1126/Science.Aan1495  0.591
2017 Wong RC, Pera MF, Pébay A. Maintenance of Human Embryonic Stem Cells by Sphingosine-1-Phosphate and Platelet-Derived Growth Factor. Methods in Molecular Biology (Clifton, N.J.). PMID 28324485 DOI: 10.1007/7651_2017_4  0.491
2017 Bellmaine SF, Ovchinnikov DA, Manallack DT, Cuddy CE, Elefanty AG, Stanley EG, Wolvetang EJ, Williams SJ, Pera M. Author response: Inhibition of DYRK1A disrupts neural lineage specificationin human pluripotent stem cells Elife. DOI: 10.7554/Elife.24502.019  0.609
2016 Ding S, Kingshott P, Thissen H, Pera M, Wang PY. Modulation of human mesenchymal and pluripotent stem cell behaviour using biophysical and biochemical cues: A review. Biotechnology and Bioengineering. PMID 27531179 DOI: 10.1002/Bit.26075  0.655
2016 Pomeroy JE, Hough SR, Davidson KC, Quaas AM, Rees JA, Pera MF. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts. Stem Cells Translational Medicine. PMID 27160704 DOI: 10.5966/Sctm.2015-0250  0.843
2016 Crombie DE, Pera MF, Delatycki MB, Pébay A. Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy. International Journal of Cardiology. 212: 37-43. PMID 27019046 DOI: 10.1016/J.Ijcard.2016.03.040  0.461
2015 Crombie DE, Van Bergen N, Davidson KC, Anjomani Virmouni S, Mckelvie PA, Chrysostomou V, Conquest A, Corben LA, Pook MA, Kulkarni T, Trounce IA, Pera MF, Delatycki MB, Pébay A. Characterization of the retinal pigment epithelium in Friedreich ataxia. Biochemistry and Biophysics Reports. 4: 141-147. PMID 29124197 DOI: 10.1016/J.Bbrep.2015.09.003  0.45
2015 Pera MF, de Wert G, Dondorp W, Lovell-Badge R, Mummery CL, Munsie M, Tam PP. What if stem cells turn into embryos in a dish? Nature Methods. 12: 917-9. PMID 26418764 DOI: 10.1038/Nmeth.3586  0.562
2015 Davidson KC, Mason EA, Pera MF. The pluripotent state in mouse and human. Development (Cambridge, England). 142: 3090-9. PMID 26395138 DOI: 10.1242/Dev.116061  0.574
2015 Denham M, Hasegawa K, Menheniott T, Rollo B, Zhang D, Hough S, Alshawaf A, Febbraro F, Ighaniyan S, Leung J, Elliott DA, Newgreen DF, Pera MF, Dottori M. Multipotent caudal neural progenitors derived from human pluripotent stem cells that give rise to lineages of the central and peripheral nervous system. Stem Cells (Dayton, Ohio). 33: 1759-70. PMID 25753817 DOI: 10.1002/Stem.1991  0.564
2015 Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi YM, Crook JM, de Sousa PA, Dvorak P, Freund C, Firpo M, Furue MK, Gokhale P, ... ... Pera M, et al. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regenerative Medicine. 10: 1-44. PMID 25675265 DOI: 10.2217/Rme.14.93  0.675
2015 Munsie M, Pera M. Regulatory loophole enables unproven autologous cell therapies to thrive in Australia. Stem Cells and Development. 34-8. PMID 25457959 DOI: 10.1089/scd.2014.0332  0.402
2015 Crombie DE, Van Bergen N, Davidson KC, Anjomani Virmouni S, Mckelvie PA, Chrysostomou V, Conquest A, Corben LA, Pook MA, Kulkarni T, Trounce IA, Pera MF, Delatycki MB, Pébay A. Characterization of the retinal pigment epithelium in Friedreich ataxia Biochemistry and Biophysics Reports. 4. DOI: 10.1016/j.bbrep.2015.09.003  0.343
2014 Pera MF. In search of naivety. Cell Stem Cell. 15: 543-5. PMID 25517463 DOI: 10.1016/J.Stem.2014.10.013  0.663
2014 Mason EA, Mar JC, Laslett AL, Pera MF, Quackenbush J, Wolvetang E, Wells CA. Gene expression variability as a unifying element of the pluripotency network. Stem Cell Reports. 3: 365-77. PMID 25254348 DOI: 10.1016/J.Stemcr.2014.06.008  0.438
2014 Bird MJ, Needham K, Frazier AE, van Rooijen J, Leung J, Hough S, Denham M, Thornton ME, Parish CL, Nayagam BA, Pera M, Thorburn DR, Thompson LH, Dottori M. Functional characterization of Friedreich ataxia iPS-derived neuronal progenitors and their integration in the adult brain. Plos One. 9: e101718. PMID 25000412 DOI: 10.1371/Journal.Pone.0101718  0.476
2014 Hough SR, Thornton M, Mason E, Mar JC, Wells CA, Pera MF. Single-cell gene expression profiles define self-renewing, pluripotent, and lineage primed states of human pluripotent stem cells. Stem Cell Reports. 2: 881-95. PMID 24936473 DOI: 10.1016/J.Stemcr.2014.04.014  0.581
2014 Davidson KC, Guymer RH, Pera MF, Pébay A. Human pluripotent stem cell strategies for age-related macular degeneration. Optometry and Vision Science : Official Publication of the American Academy of Optometry. 91: 887-93. PMID 24859130 DOI: 10.1097/Opx.0000000000000282  0.511
2014 Pera MF. Stress management: a new path to pluripotency. Cell Stem Cell. 14: 273-4. PMID 24607402 DOI: 10.1016/J.Stem.2014.02.009  0.405
2013 Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, Lothe RA, Pera MF, Colman A, Robson P, Andrews PW, Knowles BB. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Reports. 1: 379-86. PMID 24286026 DOI: 10.1016/J.Stemcr.2013.10.005  0.589
2013 Pera MF. Epigenetics, vitamin supplements and cellular reprogramming. Nature Genetics. 45: 1412-3. PMID 24270443 DOI: 10.1038/Ng.2834  0.376
2013 Kim H, Wu J, Ye S, Tai CI, Zhou X, Yan H, Li P, Pera M, Ying QL. Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nature Communications. 4: 2403. PMID 23985566 DOI: 10.1038/Ncomms3403  0.659
2013 Pera M, Trounson A. Cloning debate: Stem-cell researchers must stay engaged. Nature. 498: 159-61. PMID 23765475 DOI: 10.1038/498159A  0.574
2013 Tam PP, Pera MF. Stem cell science and regenerative medicine. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 35: 147-8. PMID 23401027 DOI: 10.1002/Bies.201300003  0.607
2013 Cunningham JJ, Ulbright TM, Pera MF, Looijenga LH. Erratum: Corrigendum: Lessons from human teratomas to guide development of safe stem cell therapies Nature Biotechnology. 31: 565-565. DOI: 10.1038/Nbt0613-565A  0.446
2012 Hasegawa K, Yasuda SY, Teo JL, Nguyen C, McMillan M, Hsieh CL, Suemori H, Nakatsuji N, Yamamoto M, Miyabayashi T, Lutzko C, Pera MF, Kahn M. Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion. Stem Cells Translational Medicine. 1: 18-28. PMID 23197636 DOI: 10.5966/Sctm.2011-0033  0.596
2012 Kearns-Jonker M, Dai W, Gunthart M, Fuentes T, Yeh HY, Gerczuk P, Pera M, Mummery C, Kloner RA. Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart. Journal of Stem Cell Research & Therapy. PMID 23125947 DOI: 10.4172/2157-7633.S1.005  0.527
2012 Pera MF, Plath K. Cell reprogramming. Current Opinion in Genetics & Development. 22: 401-2. PMID 23084811 DOI: 10.1016/J.Gde.2012.10.001  0.58
2012 Cunningham JJ, Ulbright TM, Pera MF, Looijenga LH. Lessons from human teratomas to guide development of safe stem cell therapies. Nature Biotechnology. 30: 849-57. PMID 22965062 DOI: 10.1038/Nbt.2329  0.637
2012 Stamp LA, Braxton DR, Wu J, Akopian V, Hasegawa K, Chandrasoma PT, Hawes SM, McLean C, Petrovic LM, Wang K, Pera MF. The GCTM-5 epitope associated with the mucin-like glycoprotein FCGBP marks progenitor cells in tissues of endodermal origin. Stem Cells (Dayton, Ohio). 30: 1999-2009. PMID 22761039 DOI: 10.1002/Stem.1167  0.528
2012 Lee NS, Rohan JG, Zitting M, Kamath S, Weitz A, Sipos A, Salvaterra PM, Hasegawa K, Pera M, Chow RH. A novel dual-color reporter for identifying insulin-producing beta-cells and classifying heterogeneity of insulinoma cell lines. Plos One. 7: e35521. PMID 22530041 DOI: 10.1371/Journal.Pone.0035521  0.492
2012 Wong RC, Pera MF, Pébay A. Maintenance of human embryonic stem cells by sphingosine-1-phosphate and platelet-derived growth factor. Methods in Molecular Biology (Clifton, N.J.). 874: 167-75. PMID 22528447 DOI: 10.1007/978-1-61779-800-9_13  0.61
2012 Conley BJ, Denham M, Pera MF, Dottori M. Generation of pluripotent stem cells and their developmental potential Frontiers in Pluripotent Stem Cells Research and Therapeutic Potentials: Bench-to-Bedside. 41-55. DOI: 10.2174/978160805289911201010041  0.622
2011 Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, ... ... Pera MF, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotechnology. 29: 1132-44. PMID 22119741 DOI: 10.1038/Nbt.2051  0.543
2011 Pera MF. The proteomes of native and induced pluripotent stem cells. Nature Methods. 8: 807-8. PMID 21959134 DOI: 10.1038/Nmeth.1707  0.669
2011 Pera MF. Stem cells: The dark side of induced pluripotency. Nature. 471: 46-7. PMID 21368819 DOI: 10.1038/471046A  0.564
2011 Pera MF. Safely modulating the immune system in regenerative medicine. Cell Stem Cell. 8: 246-7. PMID 21362563 DOI: 10.1016/J.Stem.2011.02.013  0.531
2011 Zhu D, Deng X, Spee C, Sonoda S, Hsieh CL, Barron E, Pera M, Hinton DR. Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival. Investigative Ophthalmology & Visual Science. 52: 1573-85. PMID 21087957 DOI: 10.1167/Iovs.10-6413  0.557
2011 Quaas A, Pomeroy J, Paulson R, Pera M. Elucidating mechanisms of reprogramming in induced pluripotent stem cells (iPSCs): immunohistochemical analysis of key factors Fertility and Sterility. 96: S103. DOI: 10.1016/J.Fertnstert.2011.07.405  0.824
2011 Quaas A, Pomeroy J, Huang G, Paulson R, Pera M. Early Markers of Reprogramming in Induced Pluripotent Stem Cells (iPSCs): A Timeline of Key Steps in the Reprogramming Process Fertility and Sterility. 95: S5. DOI: 10.1016/J.Fertnstert.2011.01.045  0.826
2010 Pera MF. Defining pluripotency. Nature Methods. 7: 885-7. PMID 21030963 DOI: 10.1038/nmeth1110-885  0.583
2010 Chung TL, Turner JP, Thaker NY, Kolle G, Cooper-White JJ, Grimmond SM, Pera MF, Wolvetang EJ. Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells Stem Cells. 28: 1782-1793. PMID 20715184 DOI: 10.1002/Stem.500  0.465
2010 Chung TL, Brena RM, Kolle G, Grimmond SM, Berman BP, Laird PW, Pera MF, Wolvetang EJ. Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells. Stem Cells (Dayton, Ohio). 28: 1848-55. PMID 20687155 DOI: 10.1002/Stem.493  0.556
2010 Hasegawa K, Zhang P, Wei Z, Pomeroy JE, Lu W, Pera MF. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion. Stem Cells (Dayton, Ohio). 28: 1338-48. PMID 20572011 DOI: 10.1002/Stem.466  0.832
2010 Hasegawa K, Pomeroy JE, Pera MF. Current technology for the derivation of pluripotent stem cell lines from human embryos. Cell Stem Cell. 6: 521-31. PMID 20569689 DOI: 10.1016/J.Stem.2010.05.010  0.837
2010 Pera MF, Tam PP. Extrinsic regulation of pluripotent stem cells. Nature. 465: 713-20. PMID 20535200 DOI: 10.1038/Nature09228  0.643
2010 Vazey EM, Dottori M, Jamshidi P, Tomas D, Pera MF, Horne M, Connor B. Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington's disease. Cell Transplantation. 19: 1055-62. PMID 20350346 DOI: 10.3727/096368910X494632  0.421
2010 Andrews PW, Benvenisty N, Knowles BB, McKay RD, Oh SK, Pera MF, Rossant J, Stacey GN. Human ES cell lines--introduction. In Vitro Cellular & Developmental Biology. Animal. 46: 167-8. PMID 20213278 DOI: 10.1007/S11626-010-9306-2  0.589
2010 Akopian V, Andrews PW, Beil S, Benvenisty N, Brehm J, Christie M, Ford A, Fox V, Gokhale PJ, Healy L, Holm F, Hovatta O, Knowles BB, Ludwig TE, ... ... Pera MF, et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cellular & Developmental Biology. Animal. 46: 247-58. PMID 20186512 DOI: 10.1007/S11626-010-9297-Z  0.617
2010 Lin SA, Kolle G, Grimmond SM, Zhou Q, Doust E, Little MH, Aronow B, Ricardo SD, Pera MF, Bertram JF, Laslett AL. Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors. Stem Cells and Development. 19: 1637-48. PMID 20143954 DOI: 10.1089/Scd.2010.0017  0.578
2010 Pera MF. O17. A novel marker for endodermal progenitor cells in tissue repair and transformation Differentiation. 80: S11. DOI: 10.1016/J.Diff.2010.09.160  0.57
2009 Andrews PW, Arias-Diaz J, Auerbach J, Alvarez M, Ahrlund-Richter L, Baker D, Benvenisty N, Ben-Josef D, Blin G, Borghese L, Borstlap J, Bruce K, Brüstle O, Buckle R, Camby C, ... ... Pera M, et al. Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes Stem Cell Reviews and Reports. 5: 301-314. PMID 20016957 DOI: 10.1007/S12015-009-9085-X  0.662
2009 Hough SR, Laslett AL, Grimmond SB, Kolle G, Pera MF. A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells. Plos One. 4: e7708. PMID 19890402 DOI: 10.1371/Journal.Pone.0007708  0.682
2009 Wei Z, Yang Y, Zhang P, Andrianakos R, Hasegawa K, Lyu J, Chen X, Bai G, Liu C, Pera M, Lu W. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. Stem Cells (Dayton, Ohio). 27: 2969-78. PMID 19816951 DOI: 10.1002/Stem.231  0.56
2009 Hannan NR, Jamshidi P, Pera MF, Wolvetang EJ. BMP-11 and myostatin support undifferentiated growth of human embryonic stem cells in feeder-free cultures. Cloning and Stem Cells. 11: 427-35. PMID 19751112 DOI: 10.1089/Clo.2009.0024  0.45
2009 Tanaka M, Jokubaitis V, Wood C, Wang Y, Brouard N, Pera M, Hearn M, Simmons P, Nakayama N. BMP inhibition stimulates WNT-dependent generation of chondrogenic mesoderm from embryonic stem cells. Stem Cell Research. 3: 126-41. PMID 19700382 DOI: 10.1016/J.Scr.2009.07.001  0.502
2009 Enver T, Pera M, Peterson C, Andrews PW. Stem cell states, fates, and the rules of attraction. Cell Stem Cell. 4: 387-97. PMID 19427289 DOI: 10.1016/J.Stem.2009.04.011  0.648
2009 Pera MF. Stem cells: Low-risk reprogramming. Nature. 458: 715-6. PMID 19360075 DOI: 10.1038/458715A  0.626
2009 Peh GSL, Lang RJ, Pera MF, Hawes SM. CD133 expression by neural progenitors derived from human embryonic stem cells and its use for their prospective isolation Stem Cells and Development. 18: 269-282. PMID 18651819 DOI: 10.1089/Scd.2008.0124  0.629
2009 Grandela C, Pera M, Grimmond S, Kolle G, Wolvetang E. Corrigendum to “p53 is required for etoposide-induced apoptosis of human embryonic stem cells” [Stem Cell Research 1 (2008) 116–128] Stem Cell Research. 3: 179. DOI: 10.1016/J.Scr.2008.12.001  0.619
2008 Li P, Tong C, Mehrian-Shai R, Jia L, Wu N, Yan Y, Maxson RE, Schulze EN, Song H, Hsieh CL, Pera MF, Ying QL. Germline competent embryonic stem cells derived from rat blastocysts. Cell. 135: 1299-310. PMID 19109898 DOI: 10.1016/J.Cell.2008.12.006  0.5
2008 Wong RC, Pera MF, Pébay A. Role of gap junctions in embryonic and somatic stem cells. Stem Cell Reviews. 4: 283-92. PMID 18704771 DOI: 10.1007/S12015-008-9038-9  0.668
2008 Bera TK, Saint Fleur A, Ha D, Yamada M, Lee Y, Lee B, Hahn Y, Kaufman DS, Pera M, Pastan I. Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. Stem Cells and Development. 17: 325-32. PMID 18447647 DOI: 10.1089/Scd.2007.0079  0.473
2008 Whetton AD, Williamson AJ, Krijgsveld J, Lee BH, Lemischka I, Oh S, Pera M, Mummery C, Heck AJ. The time is right: proteome biology of stem cells. Cell Stem Cell. 2: 215-7. PMID 18383624 DOI: 10.1016/J.Stem.2008.02.003  0.625
2008 Dottori M, Pera MF. Neural differentiation of human embryonic stem cells. Methods in Molecular Biology (Clifton, N.J.). 438: 19-30. PMID 18369746 DOI: 10.1007/978-1-59745-133-8_3  0.595
2008 Pera MF. Stem cells. A new year and a new era. Nature. 451: 135-6. PMID 18185576 DOI: 10.1038/451135A  0.641
2008 Pera MF, Hasegawa K. Simpler and safer cell reprogramming. Nature Biotechnology. 26: 59-60. PMID 18183017 DOI: 10.1038/Nbt0108-59  0.584
2008 Krijgsveld J, Whetton AD, Lee B, Lemischka I, Oh S, Pera M, Mummery C, Heck AJ. Proteome biology of stem cells: a new joint HUPO and ISSCR initiative. Molecular & Cellular Proteomics : McP. 7: 204-5. PMID 18178583 DOI: 10.1074/Mcp.H800001-Mcp200  0.668
2008 Wong RC, Tellis I, Jamshidi P, Pera M, Pébay A. Anti-apoptotic effect of sphingosine-1-phosphate and platelet-derived growth factor in human embryonic stem cells. Stem Cells and Development. 16: 989-1001. PMID 18047416 DOI: 10.1089/Scd.2007.0057  0.451
2007 Grandela C, Pera MF, Grimmond SM, Kolle G, Wolvetang EJ. p53 is required for etoposide-induced apoptosis of human embryonic stem cells. Stem Cell Research. 1: 116-28. PMID 19383392 DOI: 10.1016/J.Scr.2007.10.003  0.387
2007 Pera MF. On the road to reprogramming. Stem Cell Research. 1: 103-4. PMID 19383390 DOI: 10.1016/J.Scr.2008.03.002  0.334
2007 Filipczyk AA, Laslett AL, Mummery C, Pera MF. Differentiation is coupled to changes in the cell cycle regulatory apparatus of human embryonic stem cells. Stem Cell Research. 1: 45-60. PMID 19383386 DOI: 10.1016/J.Scr.2007.09.002  0.581
2007 Heck AJ, Mummery C, Whetton A, Oh S, Lee B, Pera M, Lemischka I, Krijgsveld J. Proteome biology of stem cells. Stem Cell Research. 1: 7-8. PMID 19383382 DOI: 10.1016/J.Scr.2007.08.001  0.638
2007 Orkin SH, Pera M. Stem cells down under-ISSCR 2007 Cell Stem Cell. 1: 271-276. PMID 18399027 DOI: 10.1016/J.Stem.2007.08.007  0.605
2007 Wolvetang EJ, Pera MF, Zuckerman KS. Gap junction mediated transport of shRNA between human embryonic stem cells. Biochemical and Biophysical Research Communications. 363: 610-5. PMID 17900528 DOI: 10.1016/J.Bbrc.2007.09.035  0.429
2007 Davidson KC, Jamshidi P, Daly R, Hearn MT, Pera MF, Dottori M. Wnt3a regulates survival, expansion, and maintenance of neural progenitors derived from human embryonic stem cells. Molecular and Cellular Neurosciences. 36: 408-15. PMID 17822920 DOI: 10.1016/J.Mcn.2007.07.013  0.489
2007 Dai W, Field LJ, Rubart M, Reuter S, Hale SL, Zweigerdt R, Graichen RE, Kay GL, Jyrala AJ, Colman A, Davidson BP, Pera M, Kloner RA. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. Journal of Molecular and Cellular Cardiology. 43: 504-16. PMID 17707399 DOI: 10.1016/J.Yjmcc.2007.07.001  0.445
2007 Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, ... ... Pera MF, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology. 25: 803-16. PMID 17572666 DOI: 10.1038/Nbt1318  0.576
2007 Ilancheran S, Michalska AE, Peh GSL, Wallace EM, Pera MF, Manuelpillai UC. Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential Biology of Reproduction. 77: 577-588. PMID 17494917 DOI: 10.1095/Biolreprod.106.055244  0.618
2007 Costa M, Dottori M, Sourris K, Jamshidi P, Hatzistavrou T, Davis R, Azzola L, Jackson S, Lim SM, Pera M, Elefanty AG, Stanley EG. A method for genetic modification of human embryonic stem cells using electroporation. Nature Protocols. 2: 792-6. PMID 17446878 DOI: 10.1038/Nprot.2007.105  0.54
2007 Laslett AL, Grimmond S, Gardiner B, Stamp L, Lin A, Hawes SM, Wormald S, Nikolic-Paterson D, Haylock D, Pera MF. Transcriptional analysis of early lineage commitment in human embryonic stem cells. Bmc Developmental Biology. 7: 12. PMID 17335568 DOI: 10.1186/1471-213X-7-12  0.662
2006 Wong RC, Dottori M, Koh KL, Nguyen LT, Pera MF, Pébay A. Gap junctions modulate apoptosis and colony growth of human embryonic stem cells maintained in a serum-free system. Biochemical and Biophysical Research Communications. 344: 181-8. PMID 16616002 DOI: 10.1016/J.Bbrc.2006.03.127  0.485
2006 Herszfeld D, Wolvetang E, Langton-Bunker E, Chung TL, Filipczyk AA, Houssami S, Jamshidi P, Koh K, Laslett AL, Michalska A, Nguyen L, Reubinoff BE, Tellis I, Auerbach JM, Ording CJ, ... ... Pera MF, et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nature Biotechnology. 24: 351-7. PMID 16501577 DOI: 10.1038/Nbt1197  0.566
2006 Taylor RA, Cowin P, Cunha GR, Pera MF, Trounson AO, Pedersen JS, Risbridger GP. Formation of human prostate tissue from embryonic stem cells. Nature Methods. 3: 179-181. PMID 16489334 DOI: 10.1038/Nmeth855  0.451
2006 FRYDENBERG M, CROWIN P, TAYLOR R, CUNHA G, PERA M, TROUNSON A, PEDERSEN J. 33
Development and maturation of human prostate from embryonic stem cellsin vivo Bju International. 97: 9-10. DOI: 10.1111/J.1464-410X.2006.06085_33.X  0.376
2006 Davidson KC, Daly R, Wolvetang EJ, Hearn MTW, Pera MF. Wnt signaling in human embryonic stem cells Cytometry Part A. 412-412. DOI: 10.1002/Cyto.A.20264  0.607
2005 Pébay A, Wong RC, Pitson SM, Wolvetang EJ, Peh GS, Filipczyk A, Koh KL, Tellis I, Nguyen LT, Pera MF. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. Stem Cells (Dayton, Ohio). 23: 1541-8. PMID 16081668 DOI: 10.1634/Stemcells.2004-0338  0.546
2005 Itsykson P, Ilouz N, Turetsky T, Goldstein RS, Pera MF, Fishbein I, Segal M, Reubinoff BE. Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Molecular and Cellular Neurosciences. 30: 24-36. PMID 16081300 DOI: 10.1016/J.Mcn.2005.05.004  0.518
2005 Andrews PW, Benvenisty N, McKay R, Pera MF, Rossant J, Semb H, Stacey GN. The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research. Nature Biotechnology. 23: 795-7. PMID 16003358 DOI: 10.1038/Nbt0705-795  0.68
2005 Costa M, Dottori M, Ng E, Hawes SM, Sourris K, Jamshidi P, Pera MF, Elefanty AG, Stanley EG. The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nature Methods. 2: 259-60. PMID 15782217 DOI: 10.1038/Nmeth748  0.624
2005 Pera MF. Stem cell culture, one step at a time. Nature Methods. 2: 164-5. PMID 15782183 DOI: 10.1038/Nmeth0305-164  0.591
2005 Stamp L, Crosby HA, Hawes SM, Strain AJ, Pera MF. A novel cell-surface marker found on human embryonic hepatoblasts and a subpopulation of hepatic biliary epithelial cells Stem Cells. 23: 103-112. PMID 15625127 DOI: 10.1634/Stemcells.2004-0147  0.54
2005 Pera MF, Dottori M. Stem cells and their developmental potential Stem Cells: From Bench to Bedside. 55-70. DOI: 10.1142/9789812569370_0004  0.589
2004 Ben-Hur T, Idelson M, Khaner H, Pera M, Reinhartz E, Itzik A, Reubinoff BE. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells (Dayton, Ohio). 22: 1246-55. PMID 15579643 DOI: 10.1634/Stemcells.2004-0094  0.468
2004 Wong RC, Pébay A, Nguyen LT, Koh KL, Pera MF. Presence of functional gap junctions in human embryonic stem cells. Stem Cells (Dayton, Ohio). 22: 883-9. PMID 15536180 DOI: 10.1634/Stemcells.22-6-883  0.545
2004 Pera MF, Trounson AO. Human embryonic stem cells: prospects for development. Development (Cambridge, England). 131: 5515-25. PMID 15509763 DOI: 10.1242/Dev.01451  0.638
2004 Pera MF, Andrade J, Houssami S, Reubinoff B, Trounson A, Stanley EG, Ward-van Oostwaard D, Mummery C. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. Journal of Cell Science. 117: 1269-80. PMID 14996946 DOI: 10.1242/Jcs.00970  0.651
2004 Pera MF. Unnatural selection of cultured human ES cells? Nature Biotechnology. 22: 42-3. PMID 14704703 DOI: 10.1038/Nbt0104-42  0.568
2004 Henegariu O, Heerema NA, Thurston V, Jung SH, Pera M, Vance GH. Characterization of gains, losses, and regional amplification in testicular germ cell tumor cell lines by comparative genomic hybridization Cancer Genetics and Cytogenetics. 148: 14-20. PMID 14697636 DOI: 10.1016/S0165-4608(03)00211-5  0.308
2004 Hawes SM, Pera MF. Identification and Maintenance of Cell Lineage Progenitors Derived from Human ES Cells Handbook of Stem Cells. 1: 501-510. DOI: 10.1016/B978-012436643-5/50057-2  0.612
2003 Pera MF, Filipczyk AA, Hawes SM, Laslett AL. Isolation, Characterization, and Differentiation of Human Embryonic Stem Cells Methods in Enzymology. 365: 429-446. PMID 14696363 DOI: 10.1016/S0076-6879(03)65030-5  0.663
2003 Laslett AL, Filipczyk AA, Pera MF. Characterization and culture of human embryonic stem cells. Trends in Cardiovascular Medicine. 13: 295-301. PMID 14522470 DOI: 10.1016/S1050-1738(03)00125-7  0.65
2003 Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation. 107: 2733-40. PMID 12742992 DOI: 10.1161/01.Cir.0000068356.38592.68  0.601
2003 Sathananthan H, Pera M, Trounson A. The fine structure of human embryonic stem cells. Reproductive Biomedicine Online. 4: 56-61. PMID 12470354 DOI: 10.1016/S1472-6483(10)61916-5  0.58
2002 Verfaillie CM, Pera MF, Lansdorp PM. Stem cells: hype and reality. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 369-91. PMID 12446433 DOI: 10.1182/Asheducation-2002.1.369  0.659
2002 Healy DL, Weston G, Pera MF, Rombauts L, Trounson AO. Human cloning 2001. Human Fertility (Cambridge, England). 5: 75-7. PMID 12082212 DOI: 10.1080/1464727022000198972  0.439
2002 Cooper S, Bennett W, Andrade J, Reubinoff BE, Thomson J, Pera MF. Biochemical properties of a keratan sulphate/chondroitin sulphate proteoglycan expressed in primate pluripotent stem cells. Journal of Anatomy. 200: 259-65. PMID 12033730 DOI: 10.1046/J.1469-7580.2002.00034.X  0.606
2002 Mummery C, Ward D, van den Brink CE, Bird SD, Doevendans PA, Opthof T, Brutel de la Riviere A, Tertoolen L, van der Heyden M, Pera M. Cardiomyocyte differentiation of mouse and human embryonic stem cells. Journal of Anatomy. 200: 233-42. PMID 12033727 DOI: 10.1046/J.1469-7580.2002.00031.X  0.561
2002 Goto T, Jones GM, Lolatgis N, Pera MF, Trounson AO, Monk M. Identification and characterisation of known and novel transcripts expressed during the final stages of human oocyte maturation. Molecular Reproduction and Development. 62: 13-28. PMID 11933157 DOI: 10.1002/Mrd.10118  0.394
2002 Pera MF. Scientific considerations relating to the ethics of the use of human embryonic stem cells in research and medicine. Reproduction, Fertility, and Development. 13: 23-9. PMID 11545161 DOI: 10.1071/Rd00077  0.648
2002 Pera MF. Overview of the Current Status of Research on Human Pluripotent Stem Cells Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 45: 123-129. DOI: 10.1007/s00103-001-0347-2  0.528
2001 Reubinoff BE, Itsykson P, Turetsky T, Pera MF, Reinhartz E, Itzik A, Ben-Hur T. Neural progenitors from human embryonic stem cells. Nature Biotechnology. 19: 1134-40. PMID 11731782 DOI: 10.1038/Nbt1201-1134  0.551
2001 Trounson A, Pera M. Human embryonic stem cells. Fertility and Sterility. 76: 660-661. PMID 11591394 DOI: 10.1016/S0015-0282(01)02880-1  0.679
2001 Reubinoff BE, Pera MF, Vajta G, Trounson AO. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Human Reproduction (Oxford, England). 16: 2187-94. PMID 11574514 DOI: 10.1093/Humrep/16.10.2187  0.654
2001 Pera MF. Human pluripotent stem cells: a progress report. Current Opinion in Genetics & Development. 11: 595-9. PMID 11532404 DOI: 10.1016/S0959-437X(00)00238-0  0.704
2001 Douglas ML, Boucaut KJ, Antalis TM, Higgins C, Pera MF, Stuttgen MA, Nicol DL. An orthotopic xenograft model of human nonseminomatous germ cell tumour British Journal of Cancer. 85: 608-611. PMID 11506503 DOI: 10.1054/Bjoc.2001.1884  0.401
2001 Pera M, Heppell J, Poulsom R, Teixeira FV, Williams J. Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa. Gut. 48: 792-796. PMID 11358897 DOI: 10.1136/Gut.48.6.792  0.316
2001 Pera MF, Trounson AO. Introduction to the 'Serono Symposium on Embryos, Embryonic Stem Cells and Transplantation' Reproduction, Fertility and Development. 13: 1. DOI: 10.1071/Rdv13N1_In  0.437
2000 Hooper JD, Bowen N, Marshall H, Cullen LM, Sood R, Daniels R, Stuttgen MA, Normyle JF, Higgs DR, Kastner DL, Ogbourne SM, Pera MF, Jazwinska EC, Antalis TM. Localization, expression and genomic structure of the gene encoding the human serine protease testisin Biochimica Et Biophysica Acta - Gene Structure and Expression. 1492: 63-71. PMID 11004480 DOI: 10.1016/S0167-4781(00)00071-3  0.345
2000 Munsie MJ, Michalska AE, O'Brien CM, Trounson AO, Pera MF, Mountford PS. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Current Biology : Cb. 10: 989-92. PMID 10985386 DOI: 10.1016/S0960-9822(00)00648-5  0.678
2000 Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nature Biotechnology. 18: 399-404. PMID 10748519 DOI: 10.1038/74447  0.686
2000 Pera MF, Herszfeld D. Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2. Reproduction, Fertility, and Development. 10: 551-5. PMID 10612460 DOI: 10.1071/Rd98097  0.656
2000 Reubinoff BE, Pera MF, Fong C, Trounson A, Bongso A. Erratum to “Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro” Nature Biotechnology. 18: 559-559. DOI: 10.1038/75450  0.652
1999 Voyle RB, Haines BP, Pera MF, Forrest R, Rathjen PD. Human germ cell tumor cell lines express novel leukemia inhibitory factor transcripts encoding differentially localized proteins. Experimental Cell Research. 249: 199-211. PMID 10366419 DOI: 10.1006/Excr.1999.4469  0.49
1999 Pera MF. Biology of human testicular germ cell tumours Reproductive Medicine Review. 7: 141-154. DOI: 10.1017/S0962279999000265  0.589
1998 Trounson AO, Pera MF. Potential benefits of cell cloning for human medicine. Reproduction, Fertility and Development. 10: 121-125. PMID 9727602 DOI: 10.1071/R98042  0.627
1998 Pera MF, Bennett W, Cerretti DP. CD30 and its ligand: possible role in regulation of teratoma stem cells. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 106: 169-72; discussion 1. PMID 9524575 DOI: 10.1111/J.1699-0463.1998.Tb01332.X  0.535
1998 Caricasole AAD, Van Schaik RHN, Zeinstra LM, Wierikx CDJ, Van Gurp RJHLM, Van Den Pol M, Looijenga LHJ, Oosterhuis JW, Pera MF, Ward A, De Bruijn D, Kramer P, De Jong FH, Van Den Eijnden-van Raaij AJM. Human growth-differentiation factor 3 (hGDF3): Developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours Oncogene. 16: 95-103. PMID 9467948 DOI: 10.1038/Sj.Onc.1201515  0.595
1996 Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata JI, Von Keitz A, Loouenga LHJ, Millán JL, Oosterhuis JW, Pera M, Sawada M, Schmoll HJ, Skakkebæk NE, Van Putten W, et al. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours International Journal of Cancer. 66: 806-816. PMID 8647654 DOI: 10.1002/(Sici)1097-0215(19960611)66:6<806::Aid-Ijc17>3.0.Co;2-0  0.45
1995 Pera MF, Köberle B, Masters JR. Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide. British Journal of Cancer. 71: 904-6. PMID 7734313 DOI: 10.1038/Bjc.1995.176  0.379
1994 Wenk J, Andrews PW, Casper J, Hata J, Pera MF, Von Keitz A, Damjanov I, Fenderson BA. Glycolipids of germ cell tumors: Extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells International Journal of Cancer. 58: 108-115. PMID 8014006 DOI: 10.1002/Ijc.2910580118  0.536
1994 Roach S, Schmid W, Pera MF. Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3 alpha in models of early endodermal cell differentiation. Experimental Cell Research. 215: 189-98. PMID 7957668 DOI: 10.1006/Excr.1994.1331  0.432
1994 Hill BT, Scanlon KJ, Hansson J, Harstrick A, Pera M, Fichtinger-Schepman AMJ, Shellard SA. Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients European Journal of Cancer. 30: 832-837. PMID 7917544 DOI: 10.1016/0959-8049(94)90301-8  0.314
1993 Roach S, Cooper S, Bennett W, Pera MF. Cultured cell lines from human teratomas: windows into tumour growth and differentiation and early human development. European Urology. 23: 82-7; discussion 87-. PMID 8477781 DOI: 10.1159/000474574  0.327
1992 Mason MD, Pera MF. Biochemical analysis and cellular location of the GCTM-2 antigen in embryonal carcinoma and in other tumour cell lines. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 123: 59-61. PMID 1660623 DOI: 10.1007/978-3-642-84485-0_6  0.459
1992 Pera MF, Cooper S, Bennet W, Crawford-Bryce I. Human embryonal carcinoma and yolk sac carcinoma in vitro: cell lineage relationships and possible paracrine growth regulatory interactions. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 123: 51-8. PMID 1660622 DOI: 10.1007/978-3-642-84485-0_5  0.522
1992 Cooper S, Pera MF, Bennett W, Finch JT. A novel keratan sulphate proteoglycan from a human embryonal carcinoma cell line. The Biochemical Journal. 959-66. PMID 1417756 DOI: 10.1042/Bj2860959  0.323
1992 Mason MD, Pera MF. Immunohistochemical and biochemical characterisation of the expression of a human embryonal carcinoma cell proteoglycan antigen in human germ cell tumours and other tissues. European Journal of Cancer (Oxford, England : 1990). 1090-8. PMID 1320911 DOI: 10.1016/0959-8049(92)90464-D  0.474
1991 Mason MD, Pera MF, Cooper S. Possible presence of an embryonal carcinoma-associated proteoglycan in the serum of patients with testicular germ cell tumours. European Journal of Cancer (Oxford, England : 1990). 27: 300. PMID 1851027 DOI: 10.1016/0277-5379(91)90529-M  0.374
1990 Pera MF, Cooper S, Mills J, Parrington JM. Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation; Research in Biological Diversity. 42: 10-23. PMID 2559868 DOI: 10.1111/J.1432-0436.1989.Tb00602.X  0.651
1989 Pera MF, Blasco-Lafita MJ, Cooper S, Mason M, Mills J, Monaghan P. Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. Differentiation; Research in Biological Diversity. 39: 139-49. PMID 3243384 DOI: 10.1111/J.1432-0436.1988.Tb00089.X  0.477
1987 Duchesne GM, Eady JJ, Peacock JH, Pera MF. A panel of human lung carcinoma lines: establishment, properties and common characteristics. British Journal of Cancer. 56: 287-93. PMID 2822071 DOI: 10.1038/Bjc.1987.191  0.414
1987 Pera MF, Blasco Lafita MJ, Mills J. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. International Journal of Cancer. 40: 334-43. PMID 2442105 DOI: 10.1002/Ijc.2910400309  0.574
1984 Parkinson EK, Pera MF, Emmerson A, Gorman PA. Differential effects of complete and second-stage tumour promoters in normal but not transformed human and mouse keratinocytes. Carcinogenesis. 5: 1071-7. PMID 6204790 DOI: 10.1093/Carcin/5.8.1071  0.43
1982 Pera MF, Sessford D, Roberts JJ. Toxicity of cisplatin and hydroxymalonatodiammine platinum (II) towards mouse bone marrow and B16 melanoma in relation to DNA binding in vivo. Biochemical Pharmacology. 31: 2273-8. PMID 6889865 DOI: 10.1016/0006-2952(82)90114-9  0.309
1981 Pera MF, Rawlings CJ, Roberts JJ. The role of DNA repair in the recovery of human cells from cisplatin toxicity. Chemico-Biological Interactions. 37: 245-61. PMID 7197201 DOI: 10.1016/0009-2797(81)90181-2  0.317
Show low-probability matches.